Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference1%
- Check46 days agoChange DetectedThe page has updated the number of study locations from 268 to 239 and added several new locations in various countries, including Argentina, Belgium, Brazil, Japan, Mexico, and New Zealand. Additionally, the contact information for the Pfizer CT.gov Call Center has been removed.SummaryDifference20%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check75 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check97 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check104 days agoChange DetectedThe website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.